Nimesulide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nimesulide" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

8doi.org

2^nd place

6web.archive.org

1^st place

5semanticscholar.org

11^th place

8^th place

3europa.eu

68^th place

117^th place

2cdsco.gov.in

low place

1pharmaceutical-drug-manufacturers.com

low place

1gob.mx

3,255^th place

4,809^th place

1handle.net

102^nd place

76^th place

1lww.com

2,769^th place

3,314^th place

1indianexpress.com

60^th place

43^rd place

1scribd.com

482^nd place

552^nd place

1indiatimes.com

17^th place

15^th place

1downtoearth.org.in

low place

6,403^rd place

1arquivo.pt

1,668^th place

1,164^th place

1irishtimes.com

266^th place

182^nd place

1corriere.it

161^st place

663^rd place

1manufacturingchemist.com

low place

1patents.google.com

1,182^nd place

725^th place

arquivo.pt

"EMA press release on nimesulide" (PDF). European Medicines Agency. September 2007. Archived from the original (PDF) on 2009-07-18.

cdsco.gov.in

"Gazette notification GSR 82(E)". CDSCO. 10 March 2011.
"The Gazette of India - Notification regarding Banning Nimesulide for animal use" (PDF). Central Drugs Standard Control Organisation. New Delhi. 30 December 2024. Retrieved 26 January 2025.{{cite web}}: CS1 maint: url-status (link)

corriere.it

Pappagallo M (23 May 2008). "Mazzette per evitare i controlli sull'Aulin". Corriere della Sera. Archived from the original on 25 May 2008.

doi.org

Caiazzo E, Ialenti A, Cicala C (April 2019). "The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?". European Journal of Pharmacology. 848: 105–111. doi:10.1016/j.ejphar.2019.01.044. PMID 30689999. S2CID 59339842.
McNaughton R, Huet G, Shakir S (January 2014). "An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making". BMJ Open. 4 (1): e004221. doi:10.1136/bmjopen-2013-004221. PMC 3902466. PMID 24435895.
Bessone F, Hernandez N, Mendizabal M, Ridruejo E, Gualano G, Fassio E, et al. (April 2021). "Serious liver injury induced by Nimesulide: an international collaborative study". Archives of Toxicology. 95 (4): 1475–1487. doi:10.1007/s00204-021-03000-8. hdl:10630/23626. PMID 33759010.
Suleyman H, Cadirci E, Albayrak A, Halici Z (2008). "Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug". Current Medicinal Chemistry. 15 (3): 278–283. doi:10.2174/092986708783497247. PMID 18333314.
Bernareggi A (October 1998). "Clinical pharmacokinetics of nimesulide". Clinical Pharmacokinetics. 35 (4): 247–274. doi:10.2165/00003088-199835040-00001. PMID 9812177. S2CID 26895870.
Rainsford KD (June 2006). "Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus". Current Medical Research and Opinion. 22 (6): 1161–1170. doi:10.1185/030079906X104849. PMID 16846549. S2CID 23004446.
Bianchi M, Broggini M (2003). "A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee". Drugs. 63 (Suppl 1): 37–46. doi:10.2165/00003495-200363001-00006. PMID 14506910. S2CID 19826636.
Laporte JR, Ibáñez L, Vidal X, Vendrell L, Leone R (2004). "Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents". Drug Safety. 27 (6): 411–420. doi:10.2165/00002018-200427060-00005. PMID 15144234. S2CID 1786767.

downtoearth.org.in

Choudhary V (7 January 2025). "Painkiller nimesulide finally banned after research confirms lethality for vultures". Down to Earth. Retrieved 26 January 2025.{{cite web}}: CS1 maint: url-status (link)

europa.eu

emea.europa.eu

"Nimesulide Tablets: Summary of Product Characteristics" (PDF). Europeans Medicines Agency. 2004. Archived from the original (PDF) on 11 June 2007.
"EMA press release on nimesulide" (PDF). European Medicines Agency. September 2007. Archived from the original (PDF) on 2009-07-18.

ema.europa.eu

"Current status: European Commission final decision". Archived from the original on 19 October 2014. Retrieved 12 November 2014.

gob.mx

"Aviso sobre los riesgos del consumo y uso de los medicamentos que contengan en su formulación Nimesulida" (in Spanish). Cofepris. 30 May 2019. Retrieved 1 July 2023.

handle.net

hdl.handle.net

Bessone F, Hernandez N, Mendizabal M, Ridruejo E, Gualano G, Fassio E, et al. (April 2021). "Serious liver injury induced by Nimesulide: an international collaborative study". Archives of Toxicology. 95 (4): 1475–1487. doi:10.1007/s00204-021-03000-8. hdl:10630/23626. PMID 33759010.

indianexpress.com

Thacker T (12 February 2011). "Nimesulide for kids to be banned, finally". The Indian Express. Retrieved 2018-05-19.

indiatimes.com

timesofindia.indiatimes.com

Singh K (3 January 2025). "Popular painkiller banned for animal use after vultures die". The Times of India. Retrieved 26 January 2025.{{cite news}}: CS1 maint: url-status (link)

irishtimes.com

"The Irish Times". www.irishtimes.com.

lww.com

journals.lww.com

Rahman SZ, Khan RA (2004). "Is nimesulide safe in a cardiovascular-Compromised patient?". Indian Journal of Pharmacology. 36: 252–3.

manufacturingchemist.com

"Italian medicines agency officials arrested in corruption probe". Manufacturing Chemist. 22 May 2008. Retrieved 2018-05-19.

nih.gov

pubmed.ncbi.nlm.nih.gov

"Nimesulide". livertox.nih.gov. 2012. PMID 31643176. Archived from the original on 23 December 2017. Retrieved 22 December 2017.
Caiazzo E, Ialenti A, Cicala C (April 2019). "The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?". European Journal of Pharmacology. 848: 105–111. doi:10.1016/j.ejphar.2019.01.044. PMID 30689999. S2CID 59339842.
Gupta P, Sachdev HP (June 2003). "Safety of oral use of nimesulide in children: systematic review of randomized controlled trials". Indian Pediatrics. 40 (6): 518–531. PMID 12824661.
McNaughton R, Huet G, Shakir S (January 2014). "An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making". BMJ Open. 4 (1): e004221. doi:10.1136/bmjopen-2013-004221. PMC 3902466. PMID 24435895.
"Nimesulide". National Institute of Diabetes and Digestive and Kidney Diseases. 2012. PMID 31643281.
Bessone F, Hernandez N, Mendizabal M, Ridruejo E, Gualano G, Fassio E, et al. (April 2021). "Serious liver injury induced by Nimesulide: an international collaborative study". Archives of Toxicology. 95 (4): 1475–1487. doi:10.1007/s00204-021-03000-8. hdl:10630/23626. PMID 33759010.
Suleyman H, Cadirci E, Albayrak A, Halici Z (2008). "Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug". Current Medicinal Chemistry. 15 (3): 278–283. doi:10.2174/092986708783497247. PMID 18333314.
Bernareggi A (October 1998). "Clinical pharmacokinetics of nimesulide". Clinical Pharmacokinetics. 35 (4): 247–274. doi:10.2165/00003088-199835040-00001. PMID 9812177. S2CID 26895870.
Rainsford KD (June 2006). "Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus". Current Medical Research and Opinion. 22 (6): 1161–1170. doi:10.1185/030079906X104849. PMID 16846549. S2CID 23004446.
Bianchi M, Broggini M (2003). "A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee". Drugs. 63 (Suppl 1): 37–46. doi:10.2165/00003495-200363001-00006. PMID 14506910. S2CID 19826636.
Laporte JR, Ibáñez L, Vidal X, Vendrell L, Leone R (2004). "Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents". Drug Safety. 27 (6): 411–420. doi:10.2165/00002018-200427060-00005. PMID 15144234. S2CID 1786767.

ncbi.nlm.nih.gov

McNaughton R, Huet G, Shakir S (January 2014). "An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making". BMJ Open. 4 (1): e004221. doi:10.1136/bmjopen-2013-004221. PMC 3902466. PMID 24435895.
"Nimesulide". National Institute of Diabetes and Digestive and Kidney Diseases. 2012. PMID 31643281.

livertox.nih.gov

"Nimesulide". livertox.nih.gov. 2012. PMID 31643176. Archived from the original on 23 December 2017. Retrieved 22 December 2017.

patents.google.com

"Nimesulide for external use".

pharmaceutical-drug-manufacturers.com

"Nimesulide, Nimesulide Tablets, Ainex Nimesulide, Nimesulide Manufacturers". www.pharmaceutical-drug-manufacturers.com. Archived from the original on 2016-03-03.

scribd.com

"Madras High Court Revokes Ban on Manufacture and Sale PPA - Adverse Effect - Medical Treatments". Scribd. Archived from the original on 2014-01-07.

semanticscholar.org

api.semanticscholar.org

Caiazzo E, Ialenti A, Cicala C (April 2019). "The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?". European Journal of Pharmacology. 848: 105–111. doi:10.1016/j.ejphar.2019.01.044. PMID 30689999. S2CID 59339842.
Bernareggi A (October 1998). "Clinical pharmacokinetics of nimesulide". Clinical Pharmacokinetics. 35 (4): 247–274. doi:10.2165/00003088-199835040-00001. PMID 9812177. S2CID 26895870.
Rainsford KD (June 2006). "Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus". Current Medical Research and Opinion. 22 (6): 1161–1170. doi:10.1185/030079906X104849. PMID 16846549. S2CID 23004446.
Bianchi M, Broggini M (2003). "A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee". Drugs. 63 (Suppl 1): 37–46. doi:10.2165/00003495-200363001-00006. PMID 14506910. S2CID 19826636.
Laporte JR, Ibáñez L, Vidal X, Vendrell L, Leone R (2004). "Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents". Drug Safety. 27 (6): 411–420. doi:10.2165/00002018-200427060-00005. PMID 15144234. S2CID 1786767.

web.archive.org

"Nimesulide". livertox.nih.gov. 2012. PMID 31643176. Archived from the original on 23 December 2017. Retrieved 22 December 2017.
"Current status: European Commission final decision". Archived from the original on 19 October 2014. Retrieved 12 November 2014.
"Nimesulide, Nimesulide Tablets, Ainex Nimesulide, Nimesulide Manufacturers". www.pharmaceutical-drug-manufacturers.com. Archived from the original on 2016-03-03.
"Nimesulide Tablets: Summary of Product Characteristics" (PDF). Europeans Medicines Agency. 2004. Archived from the original (PDF) on 11 June 2007.
"Madras High Court Revokes Ban on Manufacture and Sale PPA - Adverse Effect - Medical Treatments". Scribd. Archived from the original on 2014-01-07.
Pappagallo M (23 May 2008). "Mazzette per evitare i controlli sull'Aulin". Corriere della Sera. Archived from the original on 25 May 2008.